comparemela.com
Home
Live Updates
Daniel Gaudet, MD, PhD: Contextualizing Plozasiran Data from SHASTA-2, Upcoming MUIR Data : comparemela.com
Daniel Gaudet, MD, PhD: Contextualizing Plozasiran Data from SHASTA-2, Upcoming MUIR Data
Daniel Gaudet, MD, PhD, discusses SHASTA-2 data and what cardiologists could learn from the forthcoming 48-week MUIR trial data from EAS 2024.
Related Keywords
Daniel Gaudet ,
Eli Lilly ,
Boehringer Ingelheim ,
American College Of Cardiology ,
Novo Nordisk ,
Arrowhead Pharmaceuticals ,
Astrazeneca ,
American College ,
Annual Scientific Session ,
Arrowhead Pharmaceutical ,
New Amsterdam Pharma ,
comparemela.com © 2020. All Rights Reserved.